Cocrystal Pharma (8CC) Q2 2026 Earnings Report
DE:8CC Q2 2026 EPS Results
- Actual EPS
- -EUR 0.21
- Consensus EPS
- -EUR 0.15
- Beat/Miss
- Missed by -EUR 0.06
- One Year Ago EPS
- -EUR 0.18
DE:8CC Q2 2026 Revenue Results
- Actual Revenue
- EUR 94.02K
- Expected Revenue
- EUR 0
- Beat/Miss
- Beat by +EUR 94.02K
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 08/17/2026
- Time
- TBA
- Conference Call
- Monday, August 17, 2026
DE:8CC Upcoming Earnings
Cocrystal Pharma's next earnings date is estimated for November 16, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2026 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:8CC Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 16, 2026 | 2026 (Q3) | -0.16- | -0.17 | ― | ― |
| Aug 17, 2026 | 2026 (Q2) | -0.15-0.21 | -0.18 | -15.00% (-0.03) | |
| May 15, 2026 | 2026 (Q1) | ―-0.15 | -0.21 | 26.09% (+0.05) | |
| Mar 31, 2026 | 2025 (Q4) | -0.13-0.15 | -0.21 | 26.09% (+0.05) | |
| Nov 14, 2025 | 2025 (Q3) | -0.19-0.17 | -0.44 | 61.22% (+0.27) | |
| Aug 14, 2025 | 2025 (Q2) | -0.21-0.18 | -0.47 | 62.26% (+0.30) | |
| May 15, 2025 | 2025 (Q1) | ―-0.21 | -0.35 | 41.03% (+0.14) | |
| Mar 31, 2025 | 2024 (Q4) | -0.45-0.21 | -0.35 | 41.03% (+0.14) | |
| Nov 13, 2024 | 2024 (Q3) | -0.51-0.44 | -0.37 | -19.51% (-0.07) | |
| Aug 14, 2024 | 2024 (Q2) | -0.43-0.47 | -0.45 | -6.00% (-0.03) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
